tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

NBIX Stock Latest News

Neurocrine presents baseline data of CAH program
The FlyNeurocrine presents baseline data of CAH program
2d ago
NBIX
Neurocrine initiated with an Outperform at Evercore ISI
PremiumThe Fly
Neurocrine initiated with an Outperform at Evercore ISI
3d ago
NBIX
Neurocrine presents CAHtalyst adult study baseline characteristics, data
PremiumThe Fly
Neurocrine presents CAHtalyst adult study baseline characteristics, data
7d ago
NBIX
Neurocrine announces initiation of Phase 1 study evaluating NBI-1076986
PremiumThe Fly
Neurocrine announces initiation of Phase 1 study evaluating NBI-1076986
7d ago
NBIX
Neurocrine initiates Phase 1 clinical study of NBI-1117567 in healthy adults
PremiumThe Fly
Neurocrine initiates Phase 1 clinical study of NBI-1117567 in healthy adults
8d ago
NBIX
Neurocrine presents data from CAHtalyst Pediatric Phase 3 clinical study
PremiumThe FlyNeurocrine presents data from CAHtalyst Pediatric Phase 3 clinical study
13d ago
NBIX
Neurocrine price target raised to $150 from $140 at Citi
PremiumThe Fly
Neurocrine price target raised to $150 from $140 at Citi
13d ago
NBIX
Neurocrine price target raised to $164 from $154 at Canaccord
PremiumThe Fly
Neurocrine price target raised to $164 from $154 at Canaccord
14d ago
NBIX
Neurocrine price target raised to $216 from $200 at Oppenheimer
PremiumThe Fly
Neurocrine price target raised to $216 from $200 at Oppenheimer
14d ago
NBIX
Neurocrine price target raised to $169 from $150 at Barclays
PremiumThe Fly
Neurocrine price target raised to $169 from $150 at Barclays
14d ago
NBIX
Neurocrine price target raised to $170 from $164 at Guggenheim
PremiumThe Fly
Neurocrine price target raised to $170 from $164 at Guggenheim
14d ago
NBIX
Neurocrine price target raised to $160 from $150 at H.C. Wainwright
PremiumThe Fly
Neurocrine price target raised to $160 from $150 at H.C. Wainwright
14d ago
NBIX
Neurocrine management to meet with Oppenheimer
PremiumThe FlyNeurocrine management to meet with Oppenheimer
14d ago
NBIX
Neurocrine backs FY24 INGREZZA net product sales view $2.1B-$2.2B
PremiumThe Fly
Neurocrine backs FY24 INGREZZA net product sales view $2.1B-$2.2B
15d ago
NBIX
Neurocrine reports Q1 adjusted EPS $1.20, consensus $1.01
PremiumThe Fly
Neurocrine reports Q1 adjusted EPS $1.20, consensus $1.01
15d ago
NBIX
Neurocrine Biosciences Reports First Quarter 2024 Financial Results
PremiumPress Releases
Neurocrine Biosciences Reports First Quarter 2024 Financial Results
15d ago
NBIX
Neurocrine announces FDA approval of INGREZZA SPRINKLE capsules
PremiumThe Fly
Neurocrine announces FDA approval of INGREZZA SPRINKLE capsules
16d ago
NBIX
Neurocrine management to meet with Oppenheimer
PremiumThe Fly
Neurocrine management to meet with Oppenheimer
16d ago
NBIX
NBIX Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
NBIX Upcoming Earnings Report: What to Expect?
17d ago
NBIX
Tesla, Airbnb upgraded: Wall Street’s top analyst calls
PremiumThe FlyTesla, Airbnb upgraded: Wall Street’s top analyst calls
22d ago
GL
APA
Wells Fargo upgrades Neurocrine with pipeline ‘turning a corner’
PremiumThe Fly
Wells Fargo upgrades Neurocrine with pipeline ‘turning a corner’
23d ago
NBIX
Neurocrine upgraded to Overweight from Equal Weight at Wells Fargo
PremiumThe Fly
Neurocrine upgraded to Overweight from Equal Weight at Wells Fargo
23d ago
NBIX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >